Goiter screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 2: | Line 2: | ||
{{Goiter}} | {{Goiter}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{ARK}} | ||
==Overview== | ==Overview== | ||
Screening for goiter initially involves physical examination followed by blood tests for free [[T4]] and [[TSH]] and finally thyroid scan, [[ultrasound]] and [[biopsy]] to rule out malignanacy. | Screening for goiter initially involves physical examination followed by blood tests for free [[T4]] and [[TSH]] and finally thyroid scan, [[ultrasound]] and [[biopsy]] to rule out malignanacy. |
Revision as of 13:35, 3 October 2017
Goiter Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Goiter screening On the Web |
American Roentgen Ray Society Images of Goiter screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aravind Reddy Kothagadi M.B.B.S[2]
Overview
Screening for goiter initially involves physical examination followed by blood tests for free T4 and TSH and finally thyroid scan, ultrasound and biopsy to rule out malignanacy.
Screening
Screening for goiter includes the following approaches and progresses to the next approach based on the result of earlier screening procedure: [1][2][3][4][5][6]
- Physical exam:
- Blood Tests:
- Blood tests are carried out in order to determine whether the goiter is affecting the production of thyroid hormone.
- Further evaluation to rule out malignancy:
- Based on the results of the physical exam and blood tests, further evaluation involving the following is advised in order to rule out malignant transformation of the gland:
- Thyroid scan
- Ultrasound
- Biopsy of the gland
- Based on the results of the physical exam and blood tests, further evaluation involving the following is advised in order to rule out malignant transformation of the gland:
References
- ↑ Ladenson PW (1996). "Optimal laboratory testing for diagnosis and monitoring of thyroid nodules, goiter, and thyroid cancer". Clin. Chem. 42 (1): 183–7. PMID 8565224.
- ↑ Dietlein M, Moka D, Schmidt M, Theissen P, Schicha H (2003). "[Prevention, screening and therapy of thyroid diseases and their cost-effectiveness]". Nuklearmedizin (in German). 42 (5): 181–9. PMID 14571314.
- ↑ COLE WH, MAJARAKIS JD, SLAUGHTER DP (1949). "Incidence of carcinoma of the thyroid in nodular goiter". J Clin Endocrinol Metab. 9 (10): 1007–11. doi:10.1210/jcem-9-10-1007. PMID 18142433.
- ↑ "Reorganized text". JAMA Otolaryngol Head Neck Surg. 141 (5): 428. 2015. doi:10.1001/jamaoto.2015.0540. PMID 25996397.
- ↑ Gursoy A, Anil C, Unal AD, Demirer AN, Tutuncu NB, Erdogan MF (2008). "Clinical and epidemiological characteristics of thyroid hemiagenesis: ultrasound screening in patients with thyroid disease and normal population". Endocrine. 33 (3): 338–41. doi:10.1007/s12020-008-9095-5. PMID 19016002.
- ↑ Brander A, Viikinkoski P, Nickels J, Kivisaari L (1989). "Thyroid gland: US screening in middle-aged women with no previous thyroid disease". Radiology. 173 (2): 507–10. doi:10.1148/radiology.173.2.2678263. PMID 2678263.